 | • レポートコード：360iR22NB028 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、238ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の調査レポートでは、世界のフローサイトメトリー市場規模が2021年の4,207.81百万ドルから、2022年に4,612.65百万ドルに達すると予測しています。今後、2027年まで年平均9.79%で、7,372.67百万ドルまでに成長する見込みです。本市場調査資料では、フローサイトメトリーの世界市場を調査対象とし、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品・サービス別（付属品、フローサイトメーター器具、試薬・消耗品、サービス、ソフトウェア）分析、技術別（ビーズベースフローサイトメーター、セルベースフローサイトメーター）分析、用途別（医療、工業、研究）分析、エンドユーザー別（学術・研究機関、病院・臨床検査研究所、製薬・バイオテクノロジー企業）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを整理しました。本書ではAgilent Technologies, Inc.、Apogee Flow Systems、bd life sciences、Becton, Dickinson and Company、Bio-Rad Laboratories、Biomérieux SA、Cytek Biosciences, Inc.、Enzo Life Sciences, Inc.、GE Healthcare、GenScript Biotech Corporation、Integrated DNA Technologies, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のフローサイトメトリー市場規模：製品・サービス別 - 付属品の市場規模 - フローサイトメーター器具の市場規模 - 試薬・消耗品の市場規模 - サービスの市場規模 - ソフトウェアの市場規模 ・世界のフローサイトメトリー市場規模：技術別 - ビーズベースフローサイトメーターの市場規模 - セルベースフローサイトメーターの市場規模 ・世界のフローサイトメトリー市場規模：用途別 - 医療用フローサイトメトリーの市場規模 - 工業用フローサイトメトリーの市場規模 - 研究用フローサイトメトリーの市場規模 ・世界のフローサイトメトリー市場規模：エンドユーザー別 - 学術・研究機関における市場規模 - 病院・臨床検査研究所における市場規模 - 製薬・バイオテクノロジー企業における市場規模 ・世界のフローサイトメトリー市場規模：地域別 - 南北アメリカのフローサイトメトリー市場規模 アメリカのフローサイトメトリー市場規模 カナダのフローサイトメトリー市場規模 ブラジルのフローサイトメトリー市場規模 ... - アジア太平洋のフローサイトメトリー市場規模 日本のフローサイトメトリー市場規模 中国のフローサイトメトリー市場規模 インドのフローサイトメトリー市場規模 韓国のフローサイトメトリー市場規模 台湾のフローサイトメトリー市場規模 ... - ヨーロッパ/中東/アフリカのフローサイトメトリー市場規模 イギリスのフローサイトメトリー市場規模 ドイツのフローサイトメトリー市場規模 フランスのフローサイトメトリー市場規模 ロシアのフローサイトメトリー市場規模 ... - その他地域のフローサイトメトリー市場規模 ・競争状況 ・企業情報 |
The Global Flow Cytometry Market size was estimated at USD 4,207.81 million in 2021 and expected to reach USD 4,612.65 million in 2022, and is projected to grow at a CAGR 9.79% to reach USD 7,372.67 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Flow Cytometry to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product & Service, the market was studied across Accessories, Flow Cytometry Instruments, Reagents & Consumables, Services, and Software. The Flow Cytometry Instruments is further studied across Cell Analyzers and Cell Sorters. The Cell Analyzers is further studied across High-range Cell Analyzers, Low-range Cell Analyzers, and Mid-range Cell Analyzers. The Cell Sorters is further studied across High-range Cell Sorters, Low-range Cell Sorters, and Mid-range Cell Sorters.
Based on Technology, the market was studied across Bead-based Flow Cytometry and Cell-based Flow Cytometry.
Based on Application, the market was studied across Clinical Applications, Industrial Applications, and Research Applications. The Clinical Applications is further studied across Cancer, Hematology, Immunodeficiency Diseases, and Organ Transplantation. The Research Applications is further studied across Apoptosis, Cell Cycle Analysis, Cell Sorting, Cell Viability, Immunology, and Pharmaceuticals & Biotechnology. The Pharmaceuticals & Biotechnology is further studied across Drug Discovery, In Vitro Toxicity Testing, and Stem Cell Research.
Based on End User, the market was studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Flow Cytometry market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Flow Cytometry Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Flow Cytometry Market, including Agilent Technologies, Inc., Apogee Flow Systems, bd life sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Biomérieux SA, Cytek Biosciences, Inc., Enzo Life Sciences, Inc., GE Healthcare, GenScript Biotech Corporation, Integrated DNA Technologies, Inc., Luminex Corporation, Miltenyi Biotec, Nanocellect Biomedical, Inc., New England Biolabs (NEB), Novozymes A/S, On-Chip Biotechnologies Co., Ltd., Sartorius AG, Sony Biotechnology Inc., Stratedigm, Inc., Synthetic Genomics, Inc., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific, Inc, Twist Bioscience, and Union Biometrica, Inc. by Harvard Bioscience, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Flow Cytometry Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Flow Cytometry Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Flow Cytometry Market?
4. What is the competitive strategic window for opportunities in the Global Flow Cytometry Market?
5. What are the technology trends and regulatory frameworks in the Global Flow Cytometry Market?
6. What is the market share of the leading vendors in the Global Flow Cytometry Market?
7. What modes and strategic moves are considered suitable for entering the Global Flow Cytometry Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases such as cancer and HIV
5.1.1.2. Accessibility and availability of application-specific products
5.1.1.3. Surging public-private initiatives in the field of immunology and immune-oncology research
5.1.2. Restraints
5.1.2.1. High cost of the product and lack of trained expertise
5.1.3. Opportunities
5.1.3.1. Emerging presence of tandem flow cytometry technologies and inclusion of AI in flow cytometry
5.1.3.2. Growing preference for flow cytometry in drug discovery and development
5.1.4. Challenges
5.1.4.1. Complications pertinent to reagent development and dearth of adequate infrastructure
5.2. Cumulative Impact of COVID-19
6. Flow Cytometry Market, by Product & Service
6.1. Introduction
6.2. Accessories
6.3. Flow Cytometry Instruments
6.4.1. Cell Analyzers
6.4.2.1. High-range Cell Analyzers
6.4.2.2. Low-range Cell Analyzers
6.4.2.3. Mid-range Cell Analyzers
6.4.2. Cell Sorters
6.4.3.1. High-range Cell Sorters
6.4.3.2. Low-range Cell Sorters
6.4.3.3. Mid-range Cell Sorters
6.4. Reagents & Consumables
6.5. Services
6.6. Software
7. Flow Cytometry Market, by Technology
7.1. Introduction
7.2. Bead-based Flow Cytometry
7.3. Cell-based Flow Cytometry
8. Flow Cytometry Market, by Application
8.1. Introduction
8.2. Clinical Applications
8.3.1. Cancer
8.3.2. Hematology
8.3.3. Immunodeficiency Diseases
8.3.4. Organ Transplantation
8.3. Industrial Applications
8.4. Research Applications
8.5.1. Apoptosis
8.5.2. Cell Cycle Analysis
8.5.3. Cell Sorting
8.5.4. Cell Viability
8.5.5. Immunology
8.5.6. Pharmaceuticals & Biotechnology
8.5.7.1. Drug Discovery
8.5.7.2. In Vitro Toxicity Testing
8.5.7.3. Stem Cell Research
9. Flow Cytometry Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Clinical Testing Laboratories
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Flow Cytometry Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Flow Cytometry Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Flow Cytometry Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Apogee Flow Systems
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. bd life sciences
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Becton, Dickinson and Company
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Bio-Rad Laboratories
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Biomérieux SA
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Cytek Biosciences, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Enzo Life Sciences, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. GE Healthcare
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. GenScript Biotech Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Integrated DNA Technologies, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Luminex Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Miltenyi Biotec
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Nanocellect Biomedical, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. New England Biolabs (NEB)
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Novozymes A/S
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. On-Chip Biotechnologies Co., Ltd.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Sartorius AG
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Sony Biotechnology Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Stratedigm, Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Synthetic Genomics, Inc.
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Sysmex Corporation
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Takara Bio Inc.
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Thermo Fisher Scientific, Inc
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Twist Bioscience
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
14.26. Union Biometrica, Inc. by Harvard Bioscience, Inc
14.26.1. Business Overview
14.26.2. Key Executives
14.26.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing